U.S. STOCKS ON THE MOVE-McDonald's, New York Times, Pfizer, JPM
Brief: Enlivex Receives Notice Of Allowance For U.S. Patent Application
Brief: Enlivex Israeli Ministry Of Health Authorizes Initiation Of Phase IIb Clinical Trial Evaluating Safety And Efficacy Of Allocetra In Sepsis Patients
Brief: Enlivex Therapeutics Says On October 22, Co Entered Into At-The-Market Agreement With H.C. Wainwright & Co
Brief: Enlivex Reports Dosing Of First Two Patients In Phase Ii Clinical Trial Evaluating Allocetra In Severe And Critical Covid-19 Patients
Brief: Enlivex Says Israeli Ministry Of Health Authorizes Initiation Of Phase II Clinical Trial Evaluating Allocetra
NASDAQ RESUMED AT 10:09 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:05 AM
U.S. STOCKS ON THE MOVE-VAALCO Energy, Pfizer, Genworth Financial, Lonestar Resources
Enlivex: Surges on positive data from potential COVID-19 treatment
NASDAQ RESUMED AT 06:52 AM
Brief: Enlivex Reports Positive Allocetra Trial Results In Covid-19 Patients
NASDAQ TRADE HALT HALT NEWS PENDING AT 04:02 AM
Brief: Enlivex Announces Allowance Of New Chinese Patent Covering Allocetra Immunotherapy
Brief: Enlivex Announces Allowance Of New U.S. Patent Covering Allocetra Immunotherapy
Brief: Enlivex Says First Patient Dosed In Clinical Trial Of Allocetra In Covid-19 Patients
Brief: Enlivex Announces Allowance Of New Japanese Patent Application Covering ALLOCETRA Immunotherapy
Brief: Enlivex Therapeutics Announces New Analyses From Recently Completed Phase Ib Clinical Trial Of Allocetra In Patients With Sepsis
Brief: Enlivex Announces Initiation Of Multi-Center Phase 2 Investigator-Initiated Clinical Trial Of Allocetra In COVID-19 Patients